17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors

Clinical trial NCT00121264 · COMPLETED

Trial details

NCT number: NCT00121264
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-03-01
Primary completion: 2010-07-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.